title: Response to Pembrolizumab in a Patient with Relapsing Thymoma.
authors: Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland. Electronic address: thilo.zander@luks.ch.
authors: Thilo
authors: T
authors: Zander
authors: Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
authors: Stefan
authors: S
authors: Aebi
authors: Department of Dermatology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
authors: Anna Christina
authors: AC
authors: Rast
authors: Department of Radiology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
authors: Andrea
authors: A
authors: Zander
authors: Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
authors: Ralph
authors: R
authors: Winterhalder
authors: Department of Dermatology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
authors: Christoph
authors: C
authors: Brand
authors: Department of Pathology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
authors: Joachim
authors: J
authors: Diebold
authors: Department of Medical Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
authors: Oliver
authors: O
authors: Gautschi
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D018714:Radiotherapy, Adjuvant; D013945:Thymoma / Q000188:drug therapy* / Q000473:pathology; D013953:Thymus Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074322:Antineoplastic Agents, Immunological; C582435:pembrolizumab